NEC cost per signed retainer
NEC (necrotizing enterocolitis, cow's milk formula) carries a cost per signed retainer of $3,100–$4,800 in Q1 2026, current as of March 31, 2026, at an 8–13% signed rate and a high qualification tier. Litigation status (verified November 17, 2026): active federal mdl. Sample size and confidence interval for this row are not available; the reason is stated on each figure below rather than omitted.
Data as of Updated Q1 2026 releaseLatest published release; the next quarterly release has not been published yet
NEC litigation status & sources
Active federal MDLStatus verified on against primary sources · next check due
As of Nov 2026, MDL 3026 (N.D. Ill.) over preterm infant formula and NEC has 847 pending actions. The first federal bellwether to reach a jury ended in a defense verdict for Mead Johnson in Aug 2026; state-court cases continue separately.
- Proceeding
- MDL 3026 (Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation) (N.D. Ill.)
- Rebecca R. Pallmeyer
- Pending actions
- 847
- JPML Pending MDL Dockets by District, report date 2026-11-02
Key dates
- A federal jury returned a defense verdict for Mead Johnson in the Inman bellwether, the first MDL 3026 case tried to verdict (trial began Aug 17, 2026).
Sources
- JPMLJPML Pending MDL Dockets by District (report date Nov 2, 2026)
- CourtN.D. Ill. MDL 3026 details page
- News / secondaryJurors Find In Favor Of Mead Johnson In Baby Formula MDL Bellwether Trial (Mealey's)
- News / secondarySteptoe: defense verdict for Mead Johnson in first bellwether trial over infant formula and NEC
Marketing information for law firms, not legal advice. Litigation status changes; confirm filing posture, case criteria and deadlines with counsel before launching or continuing a campaign. How we source and date this: editorial standards.
CPR range · Q1 2026
$3,100 – $4,800
Median: n/a — Per-tort medians are not published. The dataset carries the interquartile low and high bounds for each tort; only the national median is published as a point value.
Signed rate
8–13%
Share of exclusive leads that become signed retainers.
Qualification tier
High
Relative difficulty of clearing this tort's qualifying criteria.
Litigation status
Active federal MDL
Verified November 17, 2026 against primary sources.
Sample size
n/a
Per-tort sample sizes are not broken out in the published dataset. The panel total (140 firms, $180M of annual mass tort lead spend across 16 active tort categories) is published at the panel level only, so the number of firms and the spend basis behind any single row cannot be stated.
Confidence interval
n/a
Not computable from the published dataset. Benchmarks are published as trimmed interquartile ranges, and the per-observation values a confidence interval requires are not retained in the published figures.
Unverified
No third party has reviewed this methodology or the underlying data. Mass Tort Marketing Agency sells the leads these figures price.
What third-party verification would involveNEC CPR over time
The series for NEC starts at Q1 2026. Mass Tort Marketing Agency holds one published quarter of per-tort data for this tort, so there is no trend line to draw yet — the single point is shown below, and a second point will appear when the next quarter publishes.
| Quarter | CPR low | CPR high | Note |
|---|---|---|---|
| Q4 2024 | n/a | n/a | No per-tort breakdown for Q4 2024 is held in the dataset. Only the national median is held for that quarter, which is why the per-tort trend series begins at Q1 2026. |
| Q1 2026 | $3,100 | $4,800 | Published. |
What qualifies a NEC claimant
A premature infant received Similac or Enfamil cow's-milk-based formula (not breast milk or human-milk-based formula) during a specific neonatal window, and was subsequently diagnosed with necrotizing enterocolitis.
Falloff: 28–35%. This is the qualification-failure rate at medical-record review — the share of signed retainers that fail to file — and is the highest of any active tort.
Active — what that means for acquisition
Active, with among the most technically specific criteria of any active tort. Roughly 28-35% of signed retainers fail to file because documentation of formula brand, formula batch, or gestational age cannot be produced. Firms running Tier-2 medical-record pre-screening within 72 hours of initial retainer cut filed-case falloff to 12-18%; a 20-point reduction drops effective CPR from the upper-band $4,800 to roughly $3,400.
NEC cost per lead
This dataset does not publish a cost-per-lead figure for NEC, and no CPL value is shown here rather than being derived from the CPR band. The two are related by the signed rate — CPL is approximately CPR × signed rate — but running that multiplication against a published interquartile band produces a number that looks measured and is not, so it is left out. What the benchmark does state is the signed rate: 8–13% of exclusive NEC leads become signed retainers that survive the 30-day falloff window. If you have your own CPL from a vendor quote, that signed rate is the multiplier that turns it into a comparable CPR.
Download this row
How to cite this page
Suggested citation:
Mass Tort Marketing Agency. "NEC (necrotizing enterocolitis, cow's milk formula) cost per signed retainer." Q1 2026 CPR Benchmark, published April 24, 2026. https://www.masstortmarketingagency.com/benchmarks/nec-baby-formula
- Canonical URL:
- https://www.masstortmarketingagency.com/benchmarks/nec-baby-formula
- License:
- CC BY 4.0 — reuse permitted with attribution to Mass Tort Marketing Agency CPR Benchmark, https://www.masstortmarketingagency.com/benchmarks/
Citing a number that must stay stable? Point at a dated snapshot instead of the live page — snapshot files never change.
